Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12798523 | 0.91 | NLRP3 (0.40) | NLRP3KDM4EALDH1A1EPHX2 | |
| SCHEMBL13714813 | 0.90 | NLRP3 (0.45) | NLRP3MAPT | |
| SCHEMBL13996248 | 0.90 | NLRP3 (0.45) | NLRP3MAPT | |
| SCHEMBL7940076 | 0.88 | NLRP3 (0.47) | NLRP3MAPT | |
| SCHEMBL15179071 | 0.88 | NLRP3 (0.47) | NLRP3MAPT | |
| Acetic Acid SCHEMBL28542499 | 0.88 | KDM4E (0.40) | KDM4EALDH1A1EPHX2POLBALOX15 | |
| SCHEMBL457240 | 0.87 | KDM4E (0.41) | KDM4EALDH1A1EPHX2POLBALOX15 | |
| SCHEMBL8614083 | 0.87 | EPHX2 (0.40) | NLRP3KDM4EALDH1A1EPHX2POLB | |
| SCHEMBL414809 | 0.83 | EPHX2 (0.41) | KDM4EALDH1A1EPHX2POLBALOX15 | |
| SCHEMBL8614081 | 0.82 | LMNA (0.40) | NLRP3KDM4EALDH1A1EPHX2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| EP-2634197-B1 | CATALYST FOR NORBORNENE MONOMER POLYMERIZATION AND METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO KK (JP) | 2017-05-31 | — | — | EP | disclosed |
| EP-2614091-B1 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO KK (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-8835580-B2 | Catalyst for norbornene monomer polymerization and method for producing norbornene polymer | SHOWA DENKO K.K. (JP) | 2014-09-16 | — | — | US | disclosed |
| US-8598288-B2 | Catalyst for polymerization of norbornene monomers, method for producing norbornene polymer, method for producing norbornene copolymer, norbornene polymer and transition metal complex | SHOWA DENKO K.K. (JP) | 2013-12-03 | — | — | US | disclosed |
| US-20130261271-A1 | CATALYST FOR NORBORNENE MONOMER POLYMERIZATION AND METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO K.K. (JP) | 2013-10-03 | — | — | US | disclosed |
| EP-2634197-A1 | CATALYST FOR NORBORNENE MONOMER POLYMERIZATION AND METHOD FOR PRODUCING NORBORNENE POLYMER | Showa Denko K.K. (JP) | 2013-09-04 | — | — | EP | disclosed |
| EP-2391661-B1 | NORBORNENE COPOLYMER AND PRODUCTION METHOD THEREOF | SHOWA DENKO KK (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-2614091-A2 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | Showa Denko K.K. (JP) | 2013-07-17 | — | — | EP | disclosed |
| EP-2599801-A1 | CATALYST COMPOSITION, METHOD FOR PRODUCING NORBORNENE COPOLYMER USING CATALYST COMPOSITION, NORBORNENE COPOLYMER, AND HEAT RESISTANT FILM USING COPOLYMER | Showa Denko K.K. (JP) | 2013-06-05 | — | — | EP | disclosed |
| US-20130116113-A1 | CATALYST COMPOSITION, PRODUCTION PROCESS FOR NORBORNENE BASE COPOLYMER BY USING CATALYST COMPOSITION, NORBORNENE BASE COPOLYMER AND HEAT RESISTANT FILM PREPARED BY USING THE SAME | SHOWA DENKO K.K. (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | SHOWA DENKO K.K. (JP) | 2013-03-07 | — | — | US | disclosed |
| US-8163860-B2 | Norbornene copolymer and production method thereof | SHOWA DENKO K.K. (JP) | 2012-04-24 | — | — | US | disclosed |
| WO-2012033227-A2 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO K.K. (JP) | 2012-03-15 | — | — | WO | disclosed |
| US-20110282014-A1 | NORBORNENE COPOLYMER AND PRODUCTION METHOD THEREOF | RIKEN (JP) | 2011-11-17 | — | — | US | disclosed |
| WO-2010087528-A2 | NORBORNENE COPOLYMER AND PRODUCTION METHOD THEREOF | SHOWA DENKO K.K. (JP) | 2010-08-05 | — | — | WO | disclosed |
| US-20080033134-A1 | Norbornene-based polymer film, and retardation film, polarizing plate and liquid crystal display device using a polymer film | FUJIFILM CORPORATION (JP) | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | NNMT, PPOX, DNMT1 | NLRP3 3609/4885KDM4E 3501/4885ALDH1A1 277/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | NLRP3 2623/4885KDM4E 4643/4885ALDH1A1 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.